- Home
- PARR vs CVAC Comparison
PARR vs CVAC Comparison
Compare PARR & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PARR
- CVAC
- Stock Information
- Founded
- PARR 1984
- CVAC 2000
- Country
- PARR United States
- CVAC Germany
- Employees
- PARR N/A
- CVAC N/A
- Industry
- PARR Integrated oil Companies
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- PARR Energy
- CVAC Health Care
- Exchange
- PARR Nasdaq
- CVAC Nasdaq
- Market Cap
- PARR 1.5B
- CVAC 1.2B
- IPO Year
- PARR N/A
- CVAC 2020
- Fundamental
- Price
- PARR $31.17
- CVAC $5.44
- Analyst Decision
- PARR Hold
- CVAC Hold
- Analyst Count
- PARR 6
- CVAC 3
- Target Price
- PARR $25.79
- CVAC $6.83
- AVG Volume (30 Days)
- PARR 1.6M
- CVAC 694.6K
- Earning Date
- PARR 08-05-2025
- CVAC 09-02-2025
- Dividend Yield
- PARR N/A
- CVAC N/A
- EPS Growth
- PARR N/A
- CVAC N/A
- EPS
- PARR N/A
- CVAC 1.01
- Revenue
- PARR $7,614,628,000.00
- CVAC $599,540,810.00
- Revenue This Year
- PARR N/A
- CVAC N/A
- Revenue Next Year
- PARR N/A
- CVAC $24.04
- P/E Ratio
- PARR N/A
- CVAC $5.41
- Revenue Growth
- PARR N/A
- CVAC 675.15
- 52 Week Low
- PARR $11.86
- CVAC $2.37
- 52 Week High
- PARR $35.32
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- PARR 56.29
- CVAC 53.27
- Support Level
- PARR $27.76
- CVAC $5.41
- Resistance Level
- PARR $31.97
- CVAC $5.54
- Average True Range (ATR)
- PARR 1.73
- CVAC 0.05
- MACD
- PARR 0.19
- CVAC -0.02
- Stochastic Oscillator
- PARR 84.44
- CVAC 23.08
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.